Fantini, M. ., David, J. ., Saric, O. ., Dubeykovskiy, A. ., Cui, Y. ., Mavroukakis, S. ., … Arlen, P. . Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas. Frontiers in Immunology, 8, 1899. https://doi.org/10.3389/fimmu.2017.01899 (Original work published 2017)

Lee, J. ., Nair, J. ., Zimmer, A. ., Lipkowitz, S. ., Annunziata, C. ., Merino, M. ., … Kohn, E. . (2018). Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(18)30009-3 (Original work published 2018)